AllianceBernstein’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.64M Sell
63,994
-3,952
-6% -$309K ﹤0.01% 1480
2025
Q4
$5.99M Sell
67,946
-5,451
-7% -$464K ﹤0.01% 1457
2025
Q3
$6.11M Sell
73,397
-1,102
-1% -$96K ﹤0.01% 1423
2025
Q2
$6.96M Buy
74,499
+3,919
+6% +$371K ﹤0.01% 1338
2025
Q1
$7.46M Sell
70,580
-2,359
-3% -$243K ﹤0.01% 1297
2024
Q4
$7.05M Buy
72,939
+823
+1% +$82K ﹤0.01% 1332
2024
Q3
$7.13M Buy
72,116
+2
+0% +$183 ﹤0.01% 1360
2024
Q2
$6.2M Buy
72,114
+4,530
+7% +$356K ﹤0.01% 1409
2024
Q1
$5.12M Sell
67,584
-2,090
-3% -$161K ﹤0.01% 1452
2023
Q4
$5.29M Buy
69,674
+920
+1% +$64.2K ﹤0.01% 1468
2023
Q3
$4.75M Sell
68,754
-15,000
-18% -$1.08M ﹤0.01% 1452
2023
Q2
$7.01M Buy
83,754
+15,000
+22% +$1.22M ﹤0.01% 1297
2023
Q1
$5.08M Sell
68,754
-8,401
-11% -$589K ﹤0.01% 1393
2022
Q4
$5.45M Buy
77,155
+3,373
+5% +$225K ﹤0.01% 1374
2022
Q3
$4.17M Sell
73,782
-162,502
-69% -$9.36M ﹤0.01% 1485
2022
Q2
$12.8M Buy
236,284
+159,812
+209% +$9.75M 0.01% 1016
2022
Q1
$5.09M Buy
76,472
+272
+0.4% +$16.4K ﹤0.01% 1576
2021
Q4
$4.75M Buy
76,200
+86
+0.1% +$5.76K ﹤0.01% 1649
2021
Q3
$5.46M Sell
76,114
-12,330
-14% -$837K ﹤0.01% 1560
2021
Q2
$5.72M Sell
88,444
-4,773
-5% -$295K ﹤0.01% 1535
2021
Q1
$5.58M Buy
93,217
+2,653
+3% +$152K ﹤0.01% 1502
2020
Q4
$5.03M Hold
90,564
﹤0.01% 1480
2020
Q3
$3.94M Sell
90,564
-5,940
-6% -$268K ﹤0.01% 1463
2020
Q2
$4.41M Sell
96,504
-110
-0.1% -$4.44K ﹤0.01% 1394
2020
Q1
$3.02M Buy
96,614
+1,400
+1% +$49.9K ﹤0.01% 1439
2019
Q4
$2.97M Sell
95,214
-36,250
-28% -$1.04M ﹤0.01% 1736
2019
Q3
$4M Sell
131,464
-12,450
-9% -$504K ﹤0.01% 1537
2019
Q2
$8.57M Buy
143,914
+22,400
+18% +$1.28M 0.01% 1117
2019
Q1
$7.51M Buy
121,514
+800
+0.7% +$45.4K ﹤0.01% 1183
2018
Q4
$6.74M Buy
120,714
+600
+0.5% +$35.7K 0.01% 1163
2018
Q3
$7.38M Buy
120,114
+4,100
+4% +$236K ﹤0.01% 1091
2018
Q2
$5.94M Buy
116,014
+13,470
+13% +$667K ﹤0.01% 1161
2018
Q1
$4.65M Sell
102,544
-5,840
-5% -$264K ﹤0.01% 1255
2017
Q4
$4.68M Buy
108,384
+3,700
+4% +$155K ﹤0.01% 1256
2017
Q3
$4.43M Buy
104,684
+38,020
+57% +$1.53M ﹤0.01% 1287
2017
Q2
$2.54M Buy
66,664
+8,800
+15% +$294K ﹤0.01% 1666
2017
Q1
$1.67M Sell
57,864
-9,500
-14% -$266K ﹤0.01% 1931
2016
Q4
$1.78M Hold
67,364
﹤0.01% 1919
2016
Q3
$1.64M Sell
67,364
-7,400
-10% -$171K ﹤0.01% 1920
2016
Q2
$1.48M Buy
74,764
+4,000
+6% +$76.9K ﹤0.01% 1954
2016
Q1
$1.31M Hold
70,764
﹤0.01% 1920
2015
Q4
$1.32M Hold
70,764
﹤0.01% 1956
2015
Q3
$1.69M Sell
70,764
-2,390
-3% -$56.3K ﹤0.01% 1785
2015
Q2
$1.58M Buy
73,154
+2,300
+3% +$46.7K ﹤0.01% 1987
2015
Q1
$1.36M Hold
70,854
﹤0.01% 2011
2014
Q4
$1.23M Hold
70,854
﹤0.01% 2084
2014
Q3
$842K Hold
70,854
﹤0.01% 2292
2014
Q2
$1.07M Sell
70,854
-1
-0% -$14 ﹤0.01% 2208
2014
Q1
$1.01M Buy
70,855
+1
+0% +$15 ﹤0.01% 2163
2013
Q4
$1.11M Hold
70,854
﹤0.01% 2095
2013
Q3
$859K Hold
70,854
﹤0.01% 2215
2013
Q2
$790K Buy
+70,854
New +$759K ﹤0.01% 2207

Other funds holding MMSI

AllianceBernstein's MMSI Position: Q1 2026 in Review

AllianceBernstein reduced its Merit Medical Systems (MMSI) stake by 5.8% in Q1 2026, selling an estimated $309K and leaving 63,994 shares worth $5.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

AllianceBernstein first reported a position in MMSI in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.8M in Q2 2022. 399 funds tracked by Wall St. Rank hold MMSI as of Q1 2026.

  • AllianceBernstein held 63,994 shares of Merit Medical Systems worth $5.64M as of Q1 2026.
  • AllianceBernstein sold 3,952 Merit Medical Systems shares in Q1 2026, an estimated $309K.
  • Merit Medical Systems made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1480 holding.
  • AllianceBernstein first reported a position in Merit Medical Systems in Q2 2013 and has held it in 52 quarters since.
  • AllianceBernstein's Merit Medical Systems position peaked at $12.8M in Q2 2022.
  • 399 funds tracked by Wall St. Rank held Merit Medical Systems as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.